Tharimmune, Inc. (THAR) analyst actions
Rating and price-target actions on THAR in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the THAR overview →
1 measured THAR analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Tharimmune Announces Initiation of Phase 1 Clinical Trial of TH104 and Provides Business Update | Press release | -0.38% | +1.33% |
Keep exploring
More THAR: earnings → · SEC filings → · THAR overview →